Evaluation of the protein biomarkers and the analgesic response to systemic methylene blue in patients with refractory neuropathic pain: a double-blind, controlled study.

Aim: This study was carried out in patients with neuropathic pain in order to assess the analgesic effects and changes in protein biomarkers after the administration of methylene blue (MB), a diaminophenothiazine with antioxidant and anti-inflammatory properties, and with inhibitory effects on nitric oxide.

Materials And Methods: Ten patients with chronic refractory neuropathic pain were randomized to receive either MB (10 mg/mL Methylthioninium chloride) 2 mg/kg (MB group) or MB 0.02 mg/kg (control group) infused over 60 minutes.

Gabapentin in traumatic nerve injury pain: a randomized, double-blind, placebo-controlled, cross-over, multi-center study.

A double-blind, randomized, placebo-controlled cross-over multi-center study was conducted to evaluate the efficacy and safety of gabapentin in the treatment of neuropathic pain caused by traumatic or postsurgical peripheral nerve injury, using doses up to 2400 mg/day. The study comprised a run-in period of two weeks, two treatment periods of five weeks separated by a three weeks' washout period. The primary efficacy variable was the change in the mean pain intensity score from baseline to the last week of treatment.

Swedenborg, Linnaeus and brain research--and the roles of Gustaf Retzius and Alfred Stroh in the rediscovery of Swedenborg's manuscripts.

Emanuel Swedenborg (1688-1772) at the end of his long life became famous as a visionary mystic and founder of a new religion. However, at younger age, he was recognized as a prominent mining engineer and natural philosopher, particularly interested in geology, mineralogy, cosmology, paleontology and last but not least physiology of the brain. In his Oeconomica regni animalis (1740) and in several posthumously published extensive manuscripts, he described and analyzed e.